Valproate-dependent transcriptional regulation of GLAST/EAAT1 expression: involvement of Ying-Yang 1
- PMID: 18336953
- DOI: 10.1016/j.neuint.2008.01.015
Valproate-dependent transcriptional regulation of GLAST/EAAT1 expression: involvement of Ying-Yang 1
Abstract
Valproate, a widely used anti-epileptic drug also employed in the treatment of neurological diseases such as bipolar disorder and migraine, regulates the glutamatergic and GABAergic systems, although its effects in cell physiology have not been thoroughly characterized. High concentrations of glutamate reached during abnormal neurotransmission if not removed properly, become neurotoxic. Glutamate clearance is carried out by high affinity Na(+)-dependent glutamate transporter systems. The glutamate/aspartate transporter GLAST/EAAT1 plays the major role in glutamate removal and is regulated at different levels: transcription, post-translational modifications and cytoplasmic trafficking. The aim of this work was to gain insight into a plausible effect of valproate in GLAST function. Using cultured Bergmann glia cells from chick cerebellum we demonstrate here that valproate exposure elicits a dual regulatory effect on GLAST. In the short-term, valproate increases its Na(+)-dependent [(3)H]-d-aspartate uptake activity in a cytochalasin B-sensitive manner. Interestingly, a synergism between valproate and a histone deacetylase inhibitor was observed. Long-term valproate treatment up-regulates chglast promoter activity, GLAST mRNA levels, GLAST molecules at the plasma membrane and its uptake activity. Furthermore, valproate induces histone 3 lysine 14 acetylation and regulates Ying-Yang 1 (YY1) transcriptional repression on the chglast promoter. These results suggest that valproate elicits its effect through its histone deacetylase inhibitor properties.
Similar articles
-
Glutamate-dependent transcriptional regulation of GLAST/EAAT1: a role for YY1.J Neurochem. 2007 May;101(4):1134-44. doi: 10.1111/j.1471-4159.2007.04517.x. Epub 2007 Mar 29. J Neurochem. 2007. PMID: 17394550
-
Insulin-dependent regulation of GLAST/EAAT1 in Bergmann glial cells.Neurosci Lett. 2009 Feb 20;451(2):134-8. doi: 10.1016/j.neulet.2008.12.049. Epub 2008 Dec 30. Neurosci Lett. 2009. PMID: 19135128
-
Endothelin-1 reverses the histone deacetylase inhibitor-induced increase in glial glutamate transporter transcription without affecting histone acetylation levels.Neurochem Int. 2009 Jul-Aug;55(1-3):22-7. doi: 10.1016/j.neuint.2008.12.020. Epub 2009 Feb 7. Neurochem Int. 2009. PMID: 19428803
-
Arsenite exposure downregulates EAAT1/GLAST transporter expression in glial cells.Toxicol Sci. 2011 Aug;122(2):539-50. doi: 10.1093/toxsci/kfr126. Epub 2011 May 19. Toxicol Sci. 2011. PMID: 21602192
-
Actions of sodium valproate on the central nervous system.J Physiol Pharmacol. 1999 Sep;50(3):347-65. J Physiol Pharmacol. 1999. PMID: 10574466 Review.
Cited by
-
Up-regulation of spinal glutamate transporters contributes to anti-hypersensitive effects of valproate in rats after peripheral nerve injury.Neurosci Lett. 2011 Sep 8;502(1):52-5. doi: 10.1016/j.neulet.2011.07.023. Epub 2011 Jul 23. Neurosci Lett. 2011. PMID: 21802494 Free PMC article.
-
Adenosine Receptor A1-A2a Heteromers Regulate EAAT2 Expression and Glutamate Uptake via YY1-Induced Repression of PPARγ Transcription.PPAR Res. 2020 Mar 6;2020:2410264. doi: 10.1155/2020/2410264. eCollection 2020. PPAR Res. 2020. PMID: 32206061 Free PMC article.
-
The role of astrocytic glutamate transporters GLT-1 and GLAST in neurological disorders: Potential targets for neurotherapeutics.Neuropharmacology. 2019 Dec 15;161:107559. doi: 10.1016/j.neuropharm.2019.03.002. Epub 2019 Mar 6. Neuropharmacology. 2019. PMID: 30851309 Free PMC article. Review.
-
Transcriptional Regulation of Glutamate Transporters: From Extracellular Signals to Transcription Factors.Adv Pharmacol. 2016;76:103-45. doi: 10.1016/bs.apha.2016.01.004. Epub 2016 Mar 24. Adv Pharmacol. 2016. PMID: 27288076 Free PMC article. Review.
-
Aberrant glutamatergic systems underlying impulsive behaviors: Insights from clinical and preclinical research.Prog Neuropsychopharmacol Biol Psychiatry. 2024 Dec 20;135:111107. doi: 10.1016/j.pnpbp.2024.111107. Epub 2024 Aug 2. Prog Neuropsychopharmacol Biol Psychiatry. 2024. PMID: 39098647 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources